(207 days)
Not Found
No
The document describes automated processes and software implementations for existing analytical methods and quality control, but there is no mention of AI or ML algorithms being used for analysis, interpretation, or decision-making beyond standard automation. The "Intelligent Quality Management (iQM)" is described as an "active quality process control program" with "automatic error detection, automatic correction... and automatic documentation," which aligns with traditional automated quality control systems rather than AI/ML.
No
The device is described as a "portable critical care system" that rapidly analyzes whole blood samples and provides quantitative measurements of various parameters to aid in diagnosis, not to provide therapy.
Yes
The device aids in the diagnosis of a patient's acid/base status, electrolyte and metabolite balance, and oxygen delivery capacity, and its measurements are used in the diagnosis and management of various diseases and disorders.
No
The device is a critical care system that analyzes whole blood samples using hardware components (spectrophotometric multi-component analysis, optical cell, CO-Oximetry module) and includes external solutions and evaluators, indicating it is not software-only. While software is used for certain functions (total bilirubin measurement, fetal hemoglobin correction), it is part of a larger hardware system.
Based on the provided text, the GEM Premier 4000 is indeed an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The device is explicitly stated to be used for "rapidly analyze whole blood samples at the point of health care delivery in a clinical setting and in a central laboratory." It provides "quantitative measurements" of various parameters in these samples.
- Purpose: The parameters measured "aid in the diagnosis of a patient's acid/base status, electrolyte and metabolite balance and oxygen delivery capacity." Total bilirubin measurements are used "in the diagnosis and management" of various conditions. This directly aligns with the definition of an IVD, which is used to examine specimens from the human body to provide information for the diagnosis, treatment, or prevention of disease.
- Sample Type: The device analyzes "whole blood samples" and "heparinized plasma samples," which are specimens from the human body.
- Quality Control: The description of iQM, GEM CVP, GEM System Evaluator, and GEM Hematocrit Evaluator as "quality control" and "quality assessment" systems further supports its role as an IVD, as quality control is a crucial aspect of IVD testing.
- Predicate Devices: The listed predicate devices (ABL 735 Analyzer, GEM Premier 4000 with iQM and CVF, Quantimetrix Bilirubin Control) are all known IVD devices.
Therefore, the GEM Premier 4000, as described, clearly fits the definition and purpose of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The GEM Premier 4000 is a portable critical care system for use by health care professionals to rapidly analyze whole blood samples at the point of health care delivery in a clinical setting and in a central laboratory. The instrument provides quantitative measurements of pH. BCO2 pO2, sodium. potassium, chloride, ionized calcium, glucose, lactate, hematocrit, total bilirubin and CO-Oximetry (tHb, O2Hb, COHb. MetHb, HHb) parameters. Total bilirubin can also be quantitated from heparinized plasma samples when analyzed in the tBili/CO-Ox mode. These parameters, along with derived parameters, aid in the diagnosis of a patient's acid/base status, electrolyte and metabolite balance and oxygen delivery capacity. Total bilirubin measurements are used in the diagnosis and management of biliary tract obstructions, liver disease and various hemolytic diseases and disorders involving the metabolism of bilirubin. In neonates, the level of total bilirubin is used to aid in assessing the risk of kernicterus.
Intelligent Quality Management (iQM) is used as the quality control and assessment system for the GEM Premier 4000 system. iQM is an active quality process control program designed to provide continuous monitoring of the analytical process with real-time, automatic error detection, automatic correction of the system and automatic documentation of all corrective actions, replacing the use of traditional external quality controls. Facilities should follow local, state and federal regulatory guidelines to ensure that a total quality management system is followed.
As part of this program, GEM CVP (Calibration Valuation Product) with CO-Ox, GEM CVP tBili and GEM CVP Hematocrit are external solutions intended to complete the calibration process and final accuracy assessment of the iOM cartridge calibration following warm-up. The reported values for GEM CVP (two levels for pH. blood gases, electrolytes, total bilirubin. CO-Oximetry and hematoorit) must meet IL's specifications before the iQM cartridge can be used for patient sample measurements. Once the cartridge calibration is verified, the internal iOM program monitors the status of the system during the cartridge use life.
- GEM System Evaluator is a three-level assayed quality control material intended for evaluating . performance characteristics of pH, pCO2, pO2, Electrolytes, Total Bilirubin (tBili) and CO-Oximetry on the GEM Premier 4000 analyzer.
- GEM Hematocrit Evaluator is a three-level assayed quality control material for evaluating . performance characteristics of hematocrit on the GEM Premier 4000 analyzer.
Product codes (comma separated list FDA assigned to the subject device)
CIG, MQM, JJY, GLK
Device Description
GEM Premier 4000 - Introductions / Modifications: .
- Addition of total bilirubin (tBili) measurement with whole blood and heparinized plasma on the GEM . Premier 4000 performed using spectrophotometric multi-component analysis through the instrument's existing CO-Oximetry module. Following the electrochemical measurements for blood gases, electrolytes and metabolites, a portion of the sample is chemically hemolyzed and brought into an optical cell for the CO-Oximetry measurements and the additional total bilirubin measurement. There were no hardware or mechanical changes required, and no changes to the reagent cartridge (PAK) formulation or sensors. The measurement of total bilirubin was implemented through software.
- Expansion of the low-end reportable range for total hemoglobin (tHb) parameter from 5 g/dL to 3 . g/dL through additional testing.
- Addition of a new 100 uL sample size for total bilirubin and CO-Oximetry mode only. .
- Automation of fetal hemoglobin correction for CO-Oximetry. Previously the user would input the age . of the patient to apply the correction. The new software applies the correction automatically based on the presence of fetal hemoglobin in the sample without user input.
- GEM CVP 2 with CO-Ox: This currently marketed external solution for the GEM Premier 4000 . will also be value assigned for total bilirubin. No change in formulation.
- GEM CVP 5 tBili: An additional external solution for the GEM Premier 4000, containing purified . human hemoglobin, stabilizers and biocide in a physiologically buffered matrix, is being introduced at another level of total bilirubin.
- GEM System Evaluator: Three-level aqueous buffered bicarbonate solution intended for use with . the GEM Premier 4000 analyzer, containing inorganic salts and organic metabolites, dye and biocides; equilibrated with carbon dioxide and oxygen.
- GEM Hematocrit Evaluator: Three-level aqueous buffered bicarbonate solution intended for use . on the GEM Premier 4000 analyzer, containing inorganic salts and biocides; equilibrated with carbon dioxide and oxygen.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adults and Neonates
Intended User / Care Setting
health care professionals / clinical setting and in a central laboratory
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Substantial Equivalence:
The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence to chemistry test systems and quality controls already in commercial distribution. Equivalence is demonstrated through imprecision, method comparison, interference, sample matrix and stability studies, along with software development information.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1110 Bilirubin (total or direct) test system.
(a)
Identification. A bilirubin (total or direct) test system is a device intended to measure the levels of bilirubin (total or direct) in plasma or serum. Measurements of the levels of bilirubin, an organic compound formed during the normal and abnormal distruction of red blood cells, if used in the diagnosis and treatment of liver, hemolytic hematological, and metabolic disorders, including hepatitis and gall bladder block.(b)
Classification. Class II.
0
Ko93623
Image /page/0/Picture/1 description: The image shows the logos for Werfen Group and Instrumentation Laboratory. The Werfen Group logo is on the left and consists of a globe-like symbol above the text "Werfen Group". To the right of the Werfen Group logo is the Instrumentation Laboratory logo, which consists of a geometric shape and the text "Instrumentation Laboratory".
:JUN 1 8 2010
510(k) Summary
Applicant Contact Information:
| Applicant:
Address: | Instrumentation Laboratory Co.
180 Hartwell Road
Bedford, MA 01730 | |
|-----------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------|--|
| Contact Person:
Alternate Contact:
Phone Number:
Fax Number: | Carol Marble, Regulatory Affairs Director
Gabriella Erdosy, Senior Regulatory Affairs Officer
781-861-4467
781-861-4207 | |
| Preparation Date: | June 8, 2010 | |
Proprietary Names:
GEM® Premier 4000 with iQM® (Intelligent Quality Management)
GEM® CVP 2 (Calibration Valuation Product) with CO-Ox
GEM® CVP 5 (Calibration Valuation Product) tBili
GEM® System Evaluator
GEM® Hematocrit Evaluator
Device Classification:
- . Panel: Chemistry (75)
- Regulatory Sections: CFR 21 CFR 862.1110 Bilirubin (Total or Direct) Test System . CFR 21 CFR 862.1113 Bilirubin (Total and Unbound) in the Neonate Test System CFR 21 CFR 862.1660 Quality Control Material (Assayed and Unassayed) CFR 21 CFR 864.8625 Hematocrit Control
- Class II Classifications: . Class I, Reserved Class I
Class II
- Product Codes: CIG . MQM JJY GLK
Predicate Devices:
| K991417 | ABL 735 Analyzer |
|---|---|
| K061974 | GEM Premier 4000 with iQM and CVF. |
| K860942 | Quantimetrix Bilirubin Control |
1
Device Descriptions:
GEM Premier 4000 - Introductions / Modifications: .
- Addition of total bilirubin (tBili) measurement with whole blood and heparinized plasma on the GEM . Premier 4000 performed using spectrophotometric multi-component analysis through the instrument's existing CO-Oximetry module. Following the electrochemical measurements for blood gases, electrolytes and metabolites, a portion of the sample is chemically hemolyzed and brought into an optical cell for the CO-Oximetry measurements and the additional total bilirubin measurement. There were no hardware or mechanical changes required, and no changes to the reagent cartridge (PAK) formulation or sensors. The measurement of total bilirubin was implemented through software.
- Expansion of the low-end reportable range for total hemoglobin (tHb) parameter from 5 g/dL to 3 . g/dL through additional testing.
- Addition of a new 100 uL sample size for total bilirubin and CO-Oximetry mode only. .
- Automation of fetal hemoglobin correction for CO-Oximetry. Previously the user would input the age . of the patient to apply the correction. The new software applies the correction automatically based on the presence of fetal hemoglobin in the sample without user input.
- GEM CVP 2 with CO-Ox: This currently marketed external solution for the GEM Premier 4000 . will also be value assigned for total bilirubin. No change in formulation.
- GEM CVP 5 tBili: An additional external solution for the GEM Premier 4000, containing purified . human hemoglobin, stabilizers and biocide in a physiologically buffered matrix, is being introduced at another level of total bilirubin.
- GEM System Evaluator: Three-level aqueous buffered bicarbonate solution intended for use with . the GEM Premier 4000 analyzer, containing inorganic salts and organic metabolites, dye and biocides; equilibrated with carbon dioxide and oxygen.
- GEM Hematocrit Evaluator: Three-level aqueous buffered bicarbonate solution intended for use . with the GEM Premier 4000 analyzer, containing inorganic salts and biocides; equilibrated with carbon dioxide and oxygen.
2
Device Indications for Uses:
- GEM Premier 4000 with iQM (Intelligent Quality Management) .
- GEM CVP 2 (Calibration Valuation Product) with CO-Ox .
- GEM CVP 5 (Calibration Valuation Product) tBili .
The GEM Premier 4000 is a portable critical care system for use by health care professionals to rapidly analyze whole blood samples at the point of health care delivery in a clinical setting and in a central laboratory. The instrument provides quantitative measurements of pH, pCO2, pO2, sodium, potassium, calcium, glucose, bilirubin and chloride. ionized ----------------------------------------------------------------------------------------------------------------------------------------------------------------------CO-Oximetry (tHb, O2Hb, COHb, MetHb, HHb) parameters. Total bilirubin can also be quantitated from heparinized plasma samples when analyzed in the tBili/CO-Ox mode. These parameters, along with derived parameters, aid in the diagnosis of a patient's acid/base status, electrolyte and metabolite balance and oxygen delivery capacity. Total bilirubin measurements are used in the diagnosis and management of biliary tract obstructions, liver disease and various hemolytic diseases and disorders involving the metabolism of bilirubin. In neonates, the level of total bilirubin is used to aid in assessing the risk of kernicterus.
Intelligent Quality Management (iQM) is used as the quality control and assessment system for the GEM Premier 4000 system. iQM is an active quality process control program designed to provide continuous monitoring of the analytical process with real-time, automatic error detection, automatic correction of the system and automatic documentation of all corrective actions, replacing the use of traditional external quality controls. Facilities should follow local, state and federal regulatory guidelines to ensure that a total quality management system is followed.
As part of this program, GEM CVP (Calibration Valuation Product) with CO-Ox, GEM CVP tBili and GEM CVP Hematocrit are external solutions intended to complete the calibration process and final accuracy assessment of the iQM cartridge calibration following warm-up. The reported values for GEM CVP (two levels for pH, blood gases, electrolytes, total bilirubin, CO-Oximetry and hematocrit) must meet IL's specifications before the iQM cartridge can be used for patient sample measurements. Once the cartridge calibration is verified, the internal iQM program monitors the status of the system during the cartridge use life.
- GEM System Evaluator is a three level assayed quality control material intended for evaluating . performance characteristics of pH, pCO2, pQ2, Electrolytes, Metabolites, Total Bilirubin (tBili) and CO-Oximetry on the GEM Premier 4000 analyzer.
- GEM Hematocrit Evaluator is a three-level assayed quality control material intended for evaluating . performance characteristics of hematocrit on the GEM Premier 4000 analyzer.
3
Statement of Technological Characteristics of the Device Compared to Predicate Devices:
Testing supports that the GEM Premier 4000 when used for the measurement of total billirubin (tBili) in conjunction with GEM CVP Level 2 with CO-Ox and GEM CVP 5 tBili and iQM is not materially different in intended use or performance from the ABL 735 Analyzer with traditional QC:
| Characteristic | ABL 735 Analyzer
(K991417) | GEM Premier 4000 with
Total Bilirubin (tBili) |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|
| Test Principle | Spectrophotometry | Same |
| Sample Type | Whole Blood and Heparinized Plasma | Same |
| Measured Parameter | Total Bilirubin | Same |
| Population | Adults and Neonates | Same |
| Tested Range | 0.0 to 23.5 mg/dL | 0.3 to 40.0 mg/dL |
| Controls | External Traditional QC | CVP 2 with CO-Ox and CVP 5 tBili,
in conjunction with iQM (Intelligent
Quality Management) |
| Characteristic | GEM CVP 2 with CO-Ox
(K061974) | GEM CVP 2 with CO-Ox
(Total Bilirubin Claims Added) |
| Intended Use | Calibration
Valuation
External
used to complete the
Product
calibration process of the GEM
Premier 3000 and GEM Premier 4000
analyzers prior to use with patient
samples.
NOTE: High pH, pO2. Na*, K*, CI`, | Same; except assigned with a high
total bilirubin value |
| | COHb, MetHb, HHb and low pCO2,
Ca , glucose, lactate, tHb and O2Hb
values. | |
| Formulation | Aqueous buffered bicarbonate solution
containing inorganic salts and organic
metabolites, stabilizer, dye and
biocides; equilibrated with precise
concentrations of carbon dioxide and
oxygen | Same; no change in formulation |
| Storage | Unopened ampules are stable until the
expiration date shown on the label
when stored at 2-8℃, or up to
months at room temperature
00
(15-25℃), providing storage does not
exceed the expiration date. DO NOT
FREEZE. | Same; no change in formulation |
4
Statement of Technological Characteristics of the Device Compared to Predicate Devices (Cont.):
| Characteristic | Quantimetrix QC Bilirubin
(K860942) | GEM CVP 5 tBili |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | Intended as a means of monitoring
various bilirubin assay methods to
validate quantitation of patient samples.
NOTE: Two total bilirubin levels (low
and high). | External Calibration Valuation Product
used to complete the calibration process
of the GEM Premier 4000 analyzer
prior to use with patient samples for
total bilirubin (tBili) testing.
NOTE: Low total bilirubin value. |
| Formulation | Prepared from purified bilirubin in a
human protein base. Stabilizers and
preservatives have been added. | Purified human hemoglobin, stabilizers
and biocide in a physiologically
buffered solution. |
| Storage | Store at 2-8°C | Store at 2-8°C |
| Characteristic | GEM CVP 1 and 2 with CO-Ox
(K061974) | GEM System Evaluator |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | External Calibration Valuation Product
used to complete the calibration process
of the GEM Premier 3000 and GEM
Premier 4000 analyzers prior to use
with patient samples.
NOTE: Two levels each for pH, pCO2,
pO2, Electrolytes, Metabolites, tBili
(CVP 2 only) and CO-Oximetry. | Three-level assayed quality control
material for evaluating performance
characteristics of pH, pCO2, pO2,
Electrolytes, Metabolites, Total
Bilirubin (tBili) and CO-Oximetry on
the GEM Premier 4000 analyzer. |
| Formulation | Aqueous buffered bicarbonate solution | Same |
| Stability | 2-8°C until expiration | 2-8°C until expiration |
| | 15-25°C for 8 months | 15-25°C for 4 months |
| Characteristic | GEM CVP 3 and 4 Hematocrit
(K061974) | GEM Hematocrit Evaluator |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | External Calibration Valuation Product
used to complete the calibration process
of the GEM Premier 3000 and GEM
Premier 4000 analyzers prior to use
with patient samples. | Three-level assayed quality control
material for evaluating performance
characteristics of hematocrit on the
GEM Premier 4000 analyzer. |
| | NOTE: Two levels for hematocrit. | |
| Formulation | Aqueous buffered bicarbonate solution | Same |
| Stability | 15-25°C until expiration | Same |
Substantial Equivalence:
The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence to chemistry test systems and quality controls already in commercial distribution. Equivalence is demonstrated through imprecision, method comparison, interference, sample matrix and stability studies, along with software development information.
5
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/5/Picture/12 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.
Instrumentation Laboratory Company c/o Ms. Carol Marble Regulatory Affairs Director 180 Hartwell Road Bedford, MA 01730
Food & Drug Administration 10903 New Hampshire Avenue Building 66 Silver Spring, MD 20993
JUN : 8 2010
Re: K093623
Trade Name: GEM® Premier 4000 with iQM® (Intelligent Quality Management), GEM® CVP 2 (Calibration Valuation Product) with CO-Ox, GEM® CVP 5 (Calibration Valuation Product) tBili, GEM System Evaluator, GEM Hematocrit Evaluator Regulation Number: 21 CFR §862.1110 Regulation Name: Bilirubin (Total or Direct) Test System Regulatory Class: Class II Product Codes: CIG, MQM, JJY, GLK Dated: June 02, 2010 Received: June 03, 2010
Dear Ms. Marble:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
、な
6
Page 2
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or ( 301 ) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Signature
Courtney C. Harper, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
7
Indications for Use Statement
4093623
510(k) Number (if known):
GEM® Premier 4000 with iQM® (Intelligent Quality Management) Device Names: GEM® CVP 2 (Calibration Valuation Product) with CO-Ox GEM® CVP 5 (Calibration Valuation Product) tBili
Indications for Use:
The GEM Premier 4000 is a portable critical care system for use by health care professionals to rapidly analyze whole blood samples at the point of health care delivery in a clinical setting and in a central laboratory. The instrument provides quantitative measurements of pH. BCO2 pO2, sodium. potassium, chloride, ionized calcium, glucose, lactate, hematocrit, total bilirubin and CO-Oximetry (tHb, O2Hb, COHb. MetHb, HHb) parameters. Total bilirubin can also be quantitated from heparinized plasma samples when analyzed in the tBili/CO-Ox mode. These parameters, along with derived parameters, aid in the diagnosis of a patient's acid/base status, electrolyte and metabolite balance and oxygen delivery capacity. Total bilirubin measurements are used in the diagnosis and management of biliary tract obstructions, liver disease and various hemolytic diseases and disorders involving the metabolism of bilirubin. In neonates, the level of total bilirubin is used to aid in assessing the risk of kernicterus.
Intelligent Quality Management (iQM) is used as the quality control and assessment system for the GEM Premier 4000 system. iQM is an active quality process control program designed to provide continuous monitoring of the analytical process with real-time, automatic error detection, automatic correction of the system and automatic documentation of all corrective actions, replacing the use of traditional external quality controls. Facilities should follow local, state and federal regulatory guidelines to ensure that a total quality management system is followed.
As part of this program, GEM CVP (Calibration Valuation Product) with CO-Ox, GEM CVP tBili and GEM CVP Hematocrit are external solutions intended to complete the calibration process and final accuracy assessment of the iOM cartridge calibration following warm-up. The reported values for GEM CVP (two levels for pH. blood gases, electrolytes, total bilirubin. CO-Oximetry and hematoorit) must meet IL's specifications before the iQM cartridge can be used for patient sample measurements. Once the cartridge calibration is verified, the internal iOM program monitors the status of the system during the cartridge use life.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostic Devices (O[VD)
Carol C. Benson
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K093623
Attachment G
GEM Premier 4000 System 510(k)
Page I of 2
8
Indications for Use Statement
510(k) Number (if known):
GEM® System Evaluator Device Name: GEM® Hematocrit Evaluator
Indications for Use:
- GEM System Evaluator is a three-level assayed quality control material intended for evaluating . performance characteristics of pH, pCO2, pO2, Electrolytes, Total Bilirubin (tBili) and CO-Oximetry on the GEM Premier 4000 analyzer.
- GEM Hematocrit Evaluator is a three-level assayed quality control material for evaluating . performance characteristics of hematocrit on the GEM Premier 4000 analyzer.
Prescription Use V (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Carol C. Benson
Division Sign-Off
Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K093623
Attachment G
GEM Premier 4000 System 510(k)
Page 2 of 2